News
Evwr since we tested it, our favorite docking station for Mac has been the the Sonnet Echo 20 Thunderbolt 4 SuperDock. It has ...
US-based biotechnology company Sonnet BioTherapeutics has reported positive safety outcomes from a Phase Ib/IIa trial of high-dose SON-1010 (IL12-F H AB) in combination with Genentech’s atezolizumab ...
At a glance Expert's Rating Pros ・Premium price, premium value ・Integrated high-performance SSD ・Generally stable ...
Continuing its almost 30-year legacy of Mac expansion, Sonnet's new Thunderbolt 5 hardware transforms Apple's Mac mini into a ...
Raghu Rao, Interim Chief Executive Officer and Dr. Richard Kenney, Chief Medical Officer, of Sonnet discuss the recently announced safety data ...
A rare manuscript version of Shakespeare’s Sonnet 116, discovered by Dr. Leah Veronese, reveals how the poem was politically ...
Streamers take the brunt of the internet’s name-mocking: Are you a Hulu, Tubi, or Fubo subscriber? But AI companies are just ...
“This topline safety data release from our atezolizumab combination program is another significant milestone for Sonnet’s clinical development,” concluded Raghu Rao, Sonnet’s Interim Chief ...
EDT Sonnet Biotherapeutics Holdings Inc trading halted, news pending. Don't Miss Our End of Quarter Offers: Discover the latest stocks recommended by top Wall Street analyst ...
PRINCETON, N.J., April 16, 2025 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) (the "Company" or "Sonnet"), a clinical-stage company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results